ITP - Immune Thrombocytopenia Clinical Trials

7 recruiting

Frequently Asked Questions

Common questions about ITP - Immune Thrombocytopenia clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting
Phase 2Phase 3

A Study of Efgartigimod IV in Participants From 12 Years to Less Than 18 Years of Age With Chronic Immune Thrombocytopenia (ITP)

Immune Thrombocytopenic PurpuraITPITP - Immune Thrombocytopenia+1 more
argenx24 enrolled8 locationsNCT07194850
Recruiting
Phase 1

OM336 in Autoimmune Cytopenias

ITP - Immune ThrombocytopeniaAIHA - Warm Autoimmune Hemolytic AnemiaAIHA - Cold Autoimmune Hemolytic Anemia
Ouro Medicines32 enrolled3 locationsNCT07083960
Recruiting
Phase 4

Exploring the Efficacy, Safety of a Modified Starting Dosage of Avatrombopag in Immune Throbocytopenia (ITP) - a Pilot Study

ITP - Immune Thrombocytopenia
Al-Mustansiriyah University25 enrolled1 locationNCT07133659
Recruiting
Not Applicable

Eltrombopag Induced Liver Dysfunction During Treatment of Immunethrombocytopenic Purpura

ITP - Immune Thrombocytopenia
Sohag University100 enrolled1 locationNCT07093606
Recruiting

RESTI Registry: Spanish Registry of Primary Immune Thrombocytopenia and Other Immune Thrombocytopenia

Primary Immune Thrombocytopenia (ITP)ITP - Immune Thrombocytopenia
Fundación Española de Hematología y Hemoterapía1,000 enrolled36 locationsNCT06919341
Recruiting
Not Applicable

Mesenchymal Stem Cells in the Treatment of Refractory Primary Immune Thrombocytopenia

ITP - Immune Thrombocytopenia
Guangzhou Bio-gene Technology Co., Ltd40 enrolled1 locationNCT06813157
Recruiting
Phase 1Phase 2

Efficacy and Safety of CAR-T Cells Therapy for Chronic or Refractory Primary Immune Thrombocytopenia (ITP)

ITP - Immune Thrombocytopenia
920th Hospital of Joint Logistics Support Force of People's Liberation Army of China10 enrolled1 locationNCT06352281